How big is Saudi Amarco?
How big is Saudi Amarco?

How big is Saudi Amarco?

Rishikesh Gaikwad Article rating: 4.0

Saudi Amarco, thought to be the world’s most profitable company, is planning for an IPO. It is a state-owned company in Saudi Arabia.

Ten stocks close to their 52-week low
Ten stocks close to their 52-week low

Ten stocks close to their 52-week low

Abhishek Kapoor Article rating: 4.3

The market opened higher on Monday November 25.The previous Trading session witnessed the Sensex going down by 0.48% to close at 40,382.37, while Nifty was down by 0.44% to close at 11,916.20. 

Ashoka Buildcons arm get Rs. 1,000 crores worth order, stock gains
Ashoka Buildcons arm get Rs. 1,000 crores worth order, stock gains

Ashoka Buildcons arm get Rs. 1,000 crores worth order, stock gains

Pratik Shastri Article rating: 2.5

The above order was confirmed after the company reported that the subsidiary had emerged as Lowest Bidder just last week. The reaction to the stock price was due to the confirm status of its revenue growth.

Ten stocks close to their 52-week high
Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

Abhishek Kapoor Article rating: 5.0

The market opened higher on Monday November 25.The previous Trading session witnessed the Sensex going down by 0.48% to close at 40,382.37, while Nifty was down by 0.44% to close at 11,916.20. 

Unichem climbs up by 5 per cent on ANDA approval
Unichem climbs up by 5 per cent on ANDA approval

Unichem climbs up by 5 per cent on ANDA approval

Geyatee Deshpande Article rating: 4.0

Unichem Laboratories received a receipt of ANDA approval from the United States Food and Drug Administration (USFDA) for Unichem's Atenolol Tablets USP, 25 mg, 50 mg, and 100 mg. Reacting to the news, the stock climbed by 5.21 per cent.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Abhishek Kapoor Article rating: 5.0

On 25th November,overall volumes in futures & options currently stand at 1.08 crore contracts with a turnover of Rs. 7,66,847.28 crore.

Indoco Remedies receives EIR for Goa facilities
Indoco Remedies receives EIR for Goa facilities

Indoco Remedies receives EIR for Goa facilities

Geyatee Deshpande Article rating: 1.0

Indoco Remedies has announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its sterile facility (Plant II) and solid dosages facility (Plant III), located at Verna, Goa.

RSS
First29882989299029912993299529962997Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR